Holen Sie sich die Stockscreener-App
4.23
1.76%
-0.09
Ataibeckley Inc Aktie (ATAI) Neueste Nachrichten
AtaiBeckley Inc. Cash Flow – HAM:B72 - TradingView
Total debt of AtaiBeckley Inc. – HAM:B72 - TradingView
AtaiBeckley Inc. Balance Sheet – HAM:B72 - TradingView
AtaiBeckley Inc. Trade Ideas — HAM:B72 - TradingView
AtaiBeckley (ATAI) Reports Q1 Financial Results - Insider Monkey
10 Best Penny Stocks to Buy for Long Term - Insider Monkey
These stocks are today’s movers: Fermi, AST SpaceMobile, Intel, Marvell, USA Rare Earth, Ataibeckley, and more - MSN
AtaiBeckley Inc. (NASDAQ: ATAI): Advancing Psychedelic Mental Health Therapies with Clinical Momentum - Kalkine
How AtaiBeckley’s Wider Q1 Loss But Lower Per-Share Hit At AtaiBeckley (ATAI) Has Changed Its Investment Story - simplywall.st
Trump's psychedelic drug order boosts investor interest with promise of faster reviews - marketscreener.com
A Look At AtaiBeckley (ATAI) Valuation As Share Price Momentum And DCF Signal Differ - Yahoo Finance
Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research - MSN
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings - TipRanks
H.C. Wainwright Maintains AtaiBeckley(ATAI.US) With Buy Rating, Maintains Target Price $25 - Moomoo
ATAI Technical Analysis | Trend, Signals & Chart Patterns | ATAIBECKLEY INC (NASDAQ:ATAI) - ChartMill
TD Cowen Maintains AtaiBeckley(ATAI.US) With Buy Rating - Moomoo
AtaiBeckley clinical pipeline advances toward multiple late-stage data catalysts, Jefferies says - Yahoo! Finance Canada
CCORF Maintains AtaiBeckley(ATAI.US) With Buy Rating, Maintains Target Price $15 - Moomoo
ATAI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Needham Maintains AtaiBeckley(ATAI.US) With Buy Rating, Raises Target Price to $15 - Moomoo
Psychedelic stocks soar as Trump signs order to ease access - MSN
AtaiBeckley Inc. 1Q 2026: Revenue $954K, EPS $(0.08) — 10-Q Summary - TradingView
Q1 2026 loss rises at AtaiBeckley (Nasdaq: ATAI); cash and securities detailed - Stock Titan
Small cap wrap: AtaiBeckley, Standard Uranium, 374Water, Nextsource Materials… - Proactive financial news
AtaiBeckley Reports Q1 2026 Results, Initiates BPL-003 Phase 3 for Depression, Projects Cash Runway Into 2029 - Minichart
ATAI Beckley earnings beat by $0.02, revenue topped estimates - Investing.com
AtaiBeckley Q1 Net Loss Narrows, Revenue Declines - Moomoo
AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update - Investing News Network
AtaiBeckley targets Q2 start for Phase 3 depression trial as pipeline advances - Yahoo Finance
Earnings Flash (ATAI) AtaiBeckley Posts Q1 Net Loss $0.08 a Share, vs. FactSet Est of $0.10 Loss - marketscreener.com
AtaiBeckley (NASDAQ: ATAI) details Q1 2026 loss and $209.9M cash runway - Stock Titan
Earnings Flash (ATAI) AtaiBeckley Posts Q1 Net Loss $0.08 a Share, Vs. FactSet Est of $0.10 Loss - Moomoo
Earnings Flash (ATAI) AtaiBeckley Inc. Reports Q1 Revenue $954,000, vs. FactSet Est of $130,000 - marketscreener.com
Earnings Flash (ATAI) AtaiBeckley Inc. Reports Q1 Revenue $954,000, Vs. FactSet Est of $130,000 - Moomoo
AtaiBeckley Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
How Positive Phase 2a Data For EMP-01 In Social Anxiety Disorder At AtaiBeckley (ATAI) Has Changed Its Investment Story - Sahm
AtaiBeckley (ATAI) Reports Positive Phase 2a Results for Social Anxiety Treatment EMP-01 - Insider Monkey
Number of shareholders of AtaiBeckley Inc. – XETR:B72 - TradingView
5 Best Fast Growing Penny Stocks to Buy Right Now - Insider Monkey
AtaiBeckley Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
AtaiBeckley Inc. (ATAI) Stock Analysis: Unveiling a Potential 249% Upside in the Biotech Sector - DirectorsTalk Interviews
ATAI stock soars on track for best day on Trump psychedelics push and Wall Street cheers - MSN
AtaiBeckley Is Said to Explore Options for Main Psychedelic Drug - MSN
Is AtaiBeckley (ATAI) Redefining Its Psychedelic Strategy With Standalone EMP-01 Anxiety Data? - simplywall.st
10 Health Care Stocks With Whale Alerts In Today's SessionAbbVie (NYSE:ABBV), AtaiBeckley (NASDAQ:ATAI - Benzinga
Does AtaiBeckley’s (ATAI) EMP-01 Data Hint At A Scalable MDMA Therapy Platform? - Yahoo Finance
Ataibeckley: Anxiety drug cuts social phobia symptoms by 38% - MSN
2.25%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):